Federated Hermes
LKFT icon

Federated Hermes’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Federated Hermes’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-165,000
Closed -$12.7M – 2259
2021
Q1 		$12.7M Hold
165,000
– – 0.02% 596
2020
Q4 		$16.3M Sell
165,000
-1,257,932
-88% -$154M 0.03% 520
2020
Q3 		$202M Buy
1,422,932
+1,292
+0.1% +$215K 0.47% 40
2020
Q2 		$280M Buy
1,421,640
+15,097
+1% +$3.13M 0.69% 24
2020
Q1 		$276M Sell
1,406,543
-130,219
-8% -$28M 0.81% 20
2019
Q4 		$318M Sell
1,536,762
-41,801
-3% -$7.73M 0.71% 21
2019
Q3 		$241M Sell
1,578,563
-110,285
-7% -$18.1M 0.59% 27
2019
Q2 		$218M Buy
1,688,848
+9,730
+0.6% +$1.15M 0.53% 29
2019
Q1 		$198M Buy
1,679,118
+300
+0% +$30.2K 0.49% 31
2018
Q4 		$154M Buy
1,678,818
+896
+0.1% +$90.8K 0.42% 42
2018
Q3 		$189M Buy
1,677,922
+253,159
+18% +$26.7M 0.44% 41
2018
Q2 		$131M Buy
1,424,763
+121,415
+9% +$11.8M 0.38% 54
2018
Q1 		$130M Sell
1,303,348
-47,186
-3% -$5.09M 0.38% 56
2017
Q4 		$127M Buy
1,350,534
+934
+0.1% +$88.3K 0.36% 52
2017
Q3 		$137M Sell
1,349,600
-15,000
-1% -$1.31M 0.39% 50
2017
Q2 		$104M Buy
1,364,600
+366,800
+37% +$30.9M 0.3% 61
2017
Q1 		$86M Sell
997,800
-104,973
-10% -$7.56M 0.25% 79
2016
Q4 		$70.8M Hold
1,102,773
– – 0.21% 90
2016
Q3 		$71.3M Hold
1,102,773
– – 0.21% 88
2016
Q2 		$61.2M Hold
1,102,773
– – 0.18% 94
2016
Q1 		$46.1M Hold
1,102,773
– – 0.14% 125
2015
Q4 		$69.3M Buy
1,102,773
+1,043
+0.1% +$53.3K 0.22% 92
2015
Q3 		$44.9M Buy
1,101,730
+1,730
+0.2% +$100K 0.15% 145
2015
Q2 		$56.6M Buy
+1,100,000
New +$58.4M 0.17% 128

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes's LKFT Position: Q2 2021 in Review

Federated Hermes sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 165,000 shares — an estimated $12.7M sold.

Federated Hermes first reported a position in LKFT in Q2 2015 and held it in 24 quarters. The position peaked at $318M in Q4 2019. 109 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

  • Federated Hermes reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Federated Hermes sold 165,000 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $12.7M.
  • Federated Hermes first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 24 quarters.
  • Federated Hermes's Lakefront Biotherapeutics American Depositary Shares position peaked at $318M in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.